Akers Biosciences (AKER) Stock News

NASDAQ:AKER -

2.47

-0.26 (-9.52%)

Last: 4/16/2021, 9:50:21 PM

2.43

-0.04 (-1.62%)

After Hours: 4/16/2021, 9:50:21 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

AKER Latest News, Press Relases and Analysis

All

Press Releases

4 years ago - By: Akers Biosciences, Inc.

Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger

4 years ago - By: Benzinga - Mentions: FBIO BTN LGVN UK ...

50 Biggest Movers From Yesterday

4 years ago - By: Benzinga - Mentions: AMRN NVAX RIGL RXDX ...

12 Health Care Stocks Moving In Tuesday's Intraday Session

4 years ago - By: Akers Biosciences, Inc.

Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Plans to Initiate COVID-19 Inflammatory Depression Trial

4 years ago - By: Akers Biosciences, Inc.

Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Formation of Scientific Advisory Board

4 years ago - By: Akers Biosciences, Inc.

Akers Biosciences Announces Shareholder Meeting to Vote on Business Combination with MyMD Pharmaceuticals

4 years ago - By: Akers Biosciences, Inc.

MyMD Pharmaceuticals Announces New Data on Its Lead Compound MYMD-1 from a Phenotypic Study Performed by Eurofins Discovery

5 years ago - By: Akers Biosciences, Inc.

Study Identifies Effects of Temperature Changes on SARS-CoV-2 Transmission

5 years ago - By: Akers Biosciences, Inc.

Akers Biosciences Responds to Erroneous Earnings Call Press Release

5 years ago - By: Halper Sadeh LLP - Mentions: HMSY HCAP CBMG

MERGER INVESTIGATION ALERT: Halper Sadeh LLP Encourages HMSY, HCAP, CBMG, and AKER Shareholders to Contact the Firm

5 years ago - By: Kahn Swick & Foti, LLC

AKERS BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Akers Biosciences, Inc. - AKER

5 years ago - By: PennyStocks.com - Mentions: OBLN SM KOS QEP

Looking For Hot Penny Stocks Today? 5 Making New December Highs

5 years ago - By: Akers Biosciences, Inc.

Akers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Issuance of Key Patent